These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16132376

  • 1. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [Abstract] [Full Text] [Related]

  • 2. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
    Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F.
    Eur J Cancer; 2004 Jul; 40(10):1617-23. PubMed ID: 15196549
    [Abstract] [Full Text] [Related]

  • 3. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
    Tanaka F, Yanagihara K, Otake Y, Kawano Y, Miyahara R, Takenaka K, Katakura H, Ishikawa S, Ito H, Wada H.
    Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
    Xu J, Wu S, Shi X.
    J Orthop Res; 2010 Dec; 28(12):1621-5. PubMed ID: 20973064
    [Abstract] [Full Text] [Related]

  • 6. Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC.
    Pesta M, Kulda V, Topolcan O, Safranek J, Vrzalova J, Cerny R, Holubec L.
    Anticancer Res; 2009 Nov; 29(11):4535-9. PubMed ID: 20032402
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
    Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Mar 01; 95(3):250-7. PubMed ID: 17323339
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
    Song SY, Son HJ, Nam E, Rhee JC, Park C.
    Eur J Cancer; 2006 Jan 01; 42(1):101-8. PubMed ID: 16324834
    [Abstract] [Full Text] [Related]

  • 16. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.
    Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M, Tsuboi M, Japanese Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2001 Oct 01; 122(4):803-8. PubMed ID: 11581617
    [Abstract] [Full Text] [Related]

  • 17. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y, Wada H.
    Cancer Res; 2002 Dec 01; 62(23):7124-9. PubMed ID: 12460935
    [Abstract] [Full Text] [Related]

  • 18. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
    Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Yamamoto S, Iuchi K, Aozasa K.
    Ann Surg Oncol; 2004 Jul 01; 11(7):697-704. PubMed ID: 15231524
    [Abstract] [Full Text] [Related]

  • 19. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
    Iwakiri S, Nagai S, Katakura H, Takenaka K, Date H, Wada H, Tanaka F.
    Ann Surg Oncol; 2009 Jun 01; 16(6):1678-85. PubMed ID: 19330380
    [Abstract] [Full Text] [Related]

  • 20. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
    Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I.
    Eur J Cardiothorac Surg; 2004 Apr 01; 25(4):502-8. PubMed ID: 15037262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.